Physician
Hematology
Dr. Michael P. Kosty, MD
|
|
Give Review
Michael Kosty works in the field of Hematology. He graduated from George Washington University School of Medicine. George Washington University School of Medicine is ranked 67 in research and 0 in primary care medicine He received awards:"Top MD" and "Super Doctor". Michael Kosty is a published physician as well. He has 44 publications published. The latest was: An all oral antiemetic regimen for patients undergoing high-dose chemotherapy with peripheral blood stem cell transplant. He accepts Medicare payments and is listed with Medicare.gov.
Publications
- Effectiveness and safety of post-induction phase bevacizumab treatment for patients with non-small-cell lung Cancer: results from the ARIES observational cohort study.
- Satisfaction With Work-Life Balance and the Career and Retirement Plans of US Oncologists.
- Burnout and Career Satisfaction Among US Oncologists.
- Projected supply of and demand for oncologists and radiation oncologists through 2025: an aging, better-insured population will result in shortage.
- Enhancing the american society of clinical oncology workforce information System with geographic distribution of oncologists and comparison of data sources for the num...
- Access to chemotherapy services by availability of local and visiting oncologists.
- Where do patients with Cancer in iowa receive radiation therapy?
- Tracking the workforce: the American Society of Clinical Oncology workforce information System.
- How to organize a fellowship program: lessons learned and how to include accreditation council for graduate medical education competencies in the curriculum.
- Differences in clinical trial patient attributes and outcomes according to enrollment setting.
- PC-SPES: hope or hype?
- Outcomes among African-American/non-African-American patients with advanced non-small-cell lung carcinoma: report from the Cancer and Leukemia Group B.
- Comparison of psychosocial adaptation and sexual function of survivors of advanced Hodgkin Disease treated by MOPP, ABVD, or MOPP alternating with ABVD.
- Clinical manifestations of essential thrombocythemia in young adults.
- Thrombocytopenia associated with auranofin therapy: evidence for a gold-dependent immunologic mechanism.
- Thrombotic Thrombocytopenic purpura in human immunodeficiency (HIV)-seropositive males.
- Pharmacokinetics and bioequivalence of etoposide following intravenous administration of etoposide phosphate and etoposide in patients with solid Tumors.
- 2-Chlorodeoxyadenosine activity in patients with untreated, indolent non-Hodgkin's Lymphoma.
- Placebo-controlled randomized study of hydrazine sulfate in lung Cancer.
- 2-Chlorodeoxyadenosine activity in patients with untreated chronic lymphocytic Leukemia.
- Complete hematologic remissions in chronic-phase, Philadelphia-chromosome-positive, chronic myelogenous Leukemia after 2-chlorodeoxyadenosine.
- Monoclonal antibody KS1/4-methotrexate immunoconjugate studies in non-small Cell lung carcinoma.
- Nonoperative management of non-small cell lung cancer: the current cancer and Leukemia group B experience.
- 2-Chlorodeoxyadenosine dose escalation in nonhematologic malignancies.
- Cisplatin, vinblastine, and hydrazine sulfate in advanced, non-small-cell lung Cancer: a randomized placebo-controlled, double-blind phase III study of the Cancer and ...
- Two unusual presentations of müllerian adenoSarcoma: case reports, literature review, and treatment considerations.
- Pharmacokinetic study of oral and bolus intravenous 2-chlorodeoxyadenosine in patients with malignancy.
- Prolactin-secreting pituitary Carcinoma with implants in the cheek pouch and metastases to the ovaries. A case report and literature review.
- Cladribine and mitoxantrone dose escalation in indolent non-Hodgkin's Lymphoma.
- Mutation Analysis in hereditary hemochromatosis.
- Outpatient high-dose chemotherapy with autologous stem-Cell rescue for hematologic and nonhematologic malignancies.
- A longitudinal study of quality of life in advanced non-small cell lung cancer: Cancer and Leukemia Group B (CALGB) 8931.
- An all oral antiemetic regimen for patients undergoing high-dose chemotherapy with peripheral blood stem Cell transplant.
- Is quality of life predictive of the survival of patients with advanced nonsmall Cell lung carcinoma?
- Merkel Cell carcinoma: review of 22 cases with surgical, pathologic, and therapeutic considerations.
- High-dose doxorubicin, dexrazoxane, and GM-CSF in malignant mesothelioma: a phase II study-Cancer and Leukemia Group B 9631.
- Therapy choices among older patients with lung carcinoma: an evaluation of two trials of the Cancer and Leukemia Group B.
- Oncology Workforce: Results of the ASCO 2007 Program Directors Survey.
- Results of the ASCO Study of Collaborative Practice Arrangements.
- Large Cell/neuroendocrine carcinoma.
- ACCO: ASCO core curriculum outline.
- The use of canines in the detection of human Cancers.
- Association Between Geographic Access to Cancer Care and Receipt of Radiation Therapy for Rectal Cancer.
Schools
George Washington University School Of Medicine
Naval Reg Med Center
Naval Med Center
Procedures Preformed
- Plasmapheresis
- Thoracentesis
Conditions Treated
- Acute Leukemia
- Adrenal Gland Cancer
- Anal and Rectal Cancer
- Anemia
- View All
Doctors Specialties
- Hematology
- Medical Oncology
- Oncology
Accepted Insurances
Awards
- Top MD
- Super Doctor
Education
-
Naval Medical Center -
George Washington University School of Medicine
Drug Facts
| NPI NUMBER | 1801857099 | |
| NPPES Provider LastName | KOSTY | |
| NPPES Provider FirstName | MICHAEL | |
| NPPES Provider ZIPCode | 920371027 | |
| NPPES Provider State | CA | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 2146.0 | |
| Distinct Opioid Count | 5.0 | |
| Opioid Claim Count | 215.0 | |
| Percent Opioid Claims | 10.02 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1801857099 |
| Last Name Of The Provider | KOSTY |
| First Name Of The Provider | MICHAEL |
| View All |
Similar Doctors
|
|
Dr. Darren Sigal, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. James M. Sinclair, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joshua D. Rosenberg, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Richard B. Schwab, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Peter V. Sacks, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Saskia Boisot, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Emma Z. Du, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sanford J. Shattil, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Matthew J. Wieduwilt, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Isabella G. Chen, MD |
|
|
Dr. Christina A. To, MD |